Scandion Oncology AS (STU:8VY)
€ 0.0058 0 (0%) Market Cap: 1.55 Mil Enterprise Value: -408,000.00 PE Ratio: 0 PB Ratio: 0.46 GF Score: 0/100

Q4 2023 Scandion Oncology A/S Earnings Call Transcript

Feb 28, 2024 / 09:00AM GMT
Release Date Price: €0.068708 (+4.08%)
Operator

Welcome to Scandion Oncology Q4 report 2023. (Operator Instructions)

Now I will hand the conference over to CEO, Francois Martelet; and CFO, Johnny Stilou. Please go ahead.

Francois Martelet;S;CEO
Scandion Oncology A

/-

Thank you very much, and good morning to everyone, and welcome to our quarterly four year-end report for 2023. As you heard, my name is Francois Martelet. I'm the CEO of Scandion Oncology. With me today is our Chief Financial Officer, Johnny Stilou. We will be updating you on the development and financial results from the fourth quarter of '23, as well as recent events as well. Following our presentation, we will be pleased to answer any questions you may have.

Please be informed that to best address your questions, we ask you to state this verbally. It would not be possible to put questions forward in writing, so if you have a question, please follow the operator instructions and ask verbally. Please note that you will have to dial in to the call to be able to ask a question. This cannot be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot